2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a has been researched along with chlorophyll a in 58 studies
Studies (2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a) | Trials (2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a) | Recent Studies (post-2010) (2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a) | Studies (chlorophyll a) | Trials (chlorophyll a) | Recent Studies (post-2010) (chlorophyll a) |
---|---|---|---|---|---|
69 | 5 | 39 | 20,512 | 29 | 9,862 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (12.07) | 18.2507 |
2000's | 16 (27.59) | 29.6817 |
2010's | 30 (51.72) | 24.3611 |
2020's | 5 (8.62) | 2.80 |
Authors | Studies |
---|---|
Bellnier, DA; Dougherty, TJ; Henderson, BW; Pandey, RK; Potter, WR | 1 |
Bellnier, DA; Greco, WR; Henderson, BW; Johnson, P; Parsons, JC; Potter, WR; Sitnik, TM; Vaughan, LA; Whitaker, J | 1 |
Casteel, SW; Frazier, D; McCaw, DL; Payne, JT; Rogers, K; Tompson, RV | 1 |
Crean, DH; Furukawa, K; Kato, H; Mang, TS; Yamamoto, H | 1 |
Autry, SA; Edwards, BF; Madewell, BR; Magne, ML; Rodriguez, CO; Theon, AP | 1 |
De Voss, JJ; Dickinson, RG; Gillam, EM; Hooper, WD; Munns, AJ | 1 |
Ball, DE; Kamali, F; McLaughlin, WS; Seymour, RA | 1 |
Gurfinkel, M; Gust, JD; Hawrysz, DJ; Mayer, RH; Moore, AL; Moore, TA; Muggenburg, B; Nikula, K; Pandey, R; Ralston, W; Reynolds, JS; Sevick-Muraca, EM; Tatman, D; Thompson, AB; Troy, TL | 1 |
Barone, T; Ciesielski, MJ; Dougherty, TJ; Fenstermaker, RA; Lobel, J; MacDonald, IJ; Plunkett, RJ; Pollina, J; Potter, WR | 1 |
Kalhorn, TF; Lakehal, F; Levy, RH; Wurden, CJ | 1 |
Bellnier, DA; Dougherty, TJ; Greco, WR; Loewen, GM; Nava, H; Oseroff, AR; Pandey, RK; Tsuchida, T | 1 |
Baumann, H; Evans, SS; Gollnick, SO; Henderson, BW; Maier, P; Owczarczak, B; Unger, E; Vaughan, L; Wang, WC | 1 |
Bergey, EJ; Dougherty, TJ; Morgan, J; Ohulchanskyy, TY; Oseroff, AR; Prasad, PN; Pudavar, HE; Roy, I | 1 |
Bergey, EJ; Davies, SR; Detty, MR; Gibson, SL; Hilf, R; Ohulchanskyy, TY; Oseroff, AR; Roy, I; You, Y | 1 |
Bellnier, DA; Greco, WR; Henderson, BW; Snyder, JW; Vaughan, L | 1 |
Busch, TM; Cheney, RT; Gollnick, SO; Henderson, BW; Kousis, PC; Morgan, J; Snyder, JW | 1 |
Bellnier, DA; Camacho, SH; Cheney, RT; Mazurchuk, R; Oseroff, AR; Seshadri, M; Spernyak, JA | 1 |
Bellnier, DA; Dougherty, TJ; Greco, WR; Loewen, GM; Nava, H; Oseroff, AR | 1 |
Kim, S; Ohulchanskyy, TY; Pandey, RK; Prasad, PN; Pudavar, HE | 1 |
Baumann, H; Henderson, BW; Hutson, A; Rose-John, S; Tracy, E; Wang, Y; Wei, LH | 1 |
Baumann, H; Chen, Y; Ciesielski, M; Erin, T; Fenstermaker, R; Fukuzumi, S; Kadish, KM; Liu, W; Ohkubo, K; Oseroff, A; Pandey, RK; Pandey, SK; Wenbo, E; Zhang, M | 1 |
Bellnier, DA; Foster, TH; Henderson, BW; Mazurchuk, R; Seshadri, M; Spernyak, JA; Vaughan, LA | 1 |
Batt, C; Baumann, H; Bellnier, DA; Chen, Y; Henderson, BW; Jackson, J; Missert, JR; Morgan, J; Pandey, RK; Pandey, SK; Tracy, E; Zheng, X | 1 |
Batt, C; Chen, Y; Ethirajan, M; Goswami, L; Mazurchuk, R; Missert, JR; Pandey, RK; Patel, NJ; Spernyak, JA; Turowski, S; White, WH | 1 |
Baumann, H; Cooper, MT; Henderson, BH; Keymel, K; Rigual, N; Rohrbach, D; Sunar, U; Tracy, E | 1 |
Chen, Y; Ethirajan, M; Joshi, P; Pandey, RK | 1 |
Dubey, S; Ethirajan, M; Liu, TH; Missert, J; Morgan, J; Pandey, RK; Pandey, SK; Shibata, M; Srivatsan, A; Zheng, X | 1 |
Busch, TM; Durham, A; Grossman, CE; Pickup, S; Putt, ME; Wileyto, EP | 1 |
Brackett, CM; Gollnick, SO; Maier, PG; Owczarczak, B; Ramsey, K | 1 |
Ethirajan, M; Fan, W; Goswami, LN; Gupta, A; Hah, HJ; Kim, G; Kopelman, R; Lee, YE; Morgan, J; Pandey, RK; Pera, P; Wang, S | 1 |
Allamaneni, SS; Cooper, MT; Dougherty, TJ; Henderson, BW; Nava, HR; Tan, W; Wilding, G | 1 |
Mo, W; Rohrbach, D; Sunar, U | 1 |
Anderson, MA; Gorospe, EC; Leggett, CL; Levy, M; Lutzke, LS; Sun, G; Wang, KK; Wong Kee Song, LM | 1 |
Cooper, M; Frustino, J; Henderson, B; Rigual, NR; Seshadri, M; Shafirstein, G; Sullivan, MA; Wilding, G | 1 |
Chen, Y; Goswami, LN; James, NS; Joshi, P; Ohulchanskyy, TY; Pandey, RK; Zheng, X | 1 |
Baumann, H; Bellnier, DA; Cooper, MT; Henderson, BW; Merzianu, M; Rigual, N; Rohrbach, DJ; Shafirstein, G; Sullivan, M; Sunar, U; Tan, W; Tracy, EC; Wilding, G | 1 |
Intes, X; Ozturk, MS; Rohrbach, D; Sunar, U | 1 |
Bhirde, A; Chen, X; Kiesewetter, DO; Liu, Z; Nie, L; Niu, G; Rong, P; Srivastan, A; Wang, F; Wang, W; Wang, Z; Yang, K; Yue, X | 1 |
Bellnier, DA; Gollnick, SO; Manderscheid-Kern, P; Owczarczak, B; Shams, M | 1 |
Fan, L; Liu, L; Liu, Z; Tao, L; Wang, Q; Wu, DP; Zhang, Y | 1 |
Blumenthal, R; Charron, H; Joshi, A; Puri, A; Schiff, R; Sine, J; Tata, DB; Thayer, D; Urban, C; Valim, N | 1 |
Chen, J; Gao, F; Heyes, CD; Jenkins, SV; Pandey, RK; Reynolds, KY; Srivatsan, A; Zhang, Y | 1 |
Carter, KA; Geng, J; Lin, C; Lovell, JF; Luo, D; Ortega, J; Razi, A; Shao, S | 1 |
Cooper, M; Demmy, TL; Dhillon, SS; Henderson, BW; Loewen, G; Nwogu, C; Yendamuri, S | 1 |
Kim, MM; Liu, B; Penjweini, R; Zhu, TC | 1 |
Chen, L; Xiao, Q; Yang, J; Zhang, X | 1 |
Busch, TM; Carter, SL; Czupryna, J; Grossman, CE; Putt, ME; Wang, L | 1 |
Baumann, H; Chen, Y; Cheruku, RR; Joshi, P; Marko, A; Missert, JR; Ohulchanskyy, TY; Pandey, RK; Pera, P; Rohrbach, D; Saenz, C; Sunar, U; Tabaczynski, WA; Tracy, E | 1 |
Bigliardi, PL; Bigliardi-Qi, M; Burkett, BA; Eberle, AN; Krishnan-Kutty, V; Pant, A; Rout, B; Srinivas, R | 1 |
Cheruku, RR; James, NS; Missert, JR; Pandey, RK; Sunar, U | 1 |
Baumann, H; Bowman, MJ; Pandey, RK; Tracy, EC | 1 |
Cao, Q; Chen, L; Tong, H; Wang, X; Wu, Y; Yang, J; Zhang, T; Zhang, X | 1 |
Dubey, SK; Krishna, KV; Puri, A; Saha, RN; Shapiro, BA; Viard, M | 1 |
Busch, TM; Cengel, KA; Dimofte, A; Finlay, JC; Friedberg, JS; Glatstein, E; Kim, MM; Liang, X; Ong, Y; Simone, CB; Zhu, TC | 1 |
Borah, B; Cacaccio, J; Cheruku, RR; Durrani, F; Ethirajan, M; Missert, JR; Pandey, RK; Pera, P; Tabaczynski, W | 1 |
Bricks, JL; Chepurna, OM; Levchenko, SM; Losytskyy, MY; Nikolaeva, OA; Ohulchanskyy, TY; Qu, J; Slominskii, YL; Vretik, LO; Xu, H; Yakovliev, A; Ziniuk, R | 1 |
Cheruku, RR; Dukh, M; Missert, JR; Pandey, RK; Patel, NJ; Spernyak, JA; Tabaczynski, W; White, WH; Zhang, S | 1 |
Borah, BM; Bshara, W; Cacaccio, J; Durrani, FA; Pandey, RK; Spernyak, JA; Turowski, SG | 1 |
2 review(s) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and chlorophyll a
Article | Year |
---|---|
The role of porphyrin chemistry in tumor imaging and photodynamic therapy.
Topics: Animals; Chlorophyll; Esophageal Neoplasms; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2011 |
Mesoscopic fluorescence tomography of a photosensitizer (HPPH) 3D biodistribution in skin cancer.
Topics: Administration, Topical; Animals; Carcinoma, Basal Cell; Chlorophyll; Dermoscopy; Imaging, Three-Dimensional; Mice; Mice, Transgenic; Microscopy, Fluorescence; Photosensitizing Agents; Reproducibility of Results; Sensitivity and Specificity; Skin Absorption; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution; Tomography, Optical | 2014 |
5 trial(s) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and chlorophyll a
Article | Year |
---|---|
Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Barrett Esophagus; Chlorophyll; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Administration Schedule; Esophageal Neoplasms; Esophagoscopy; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Treatment Outcome | 2011 |
Adjuvant intraoperative photodynamic therapy in head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Chlorophyll; Female; Head and Neck Neoplasms; Humans; Intraoperative Care; Lasers; Male; Photochemotherapy; Treatment Outcome | 2013 |
Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chlorophyll; Disease-Free Survival; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents; STAT3 Transcription Factor; Tissue Distribution; Treatment Outcome | 2013 |
A Phase I Study of Light Dose for Photodynamic Therapy Using 2-[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a for the Treatment of Non-Small Cell Carcinoma In Situ or Non-Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study.
Topics: Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Chlorophyll; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents | 2016 |
Development and application of a physiologically based pharmacokinetic model for HPPH in rats and extrapolate to humans.
Topics: Animals; Chlorophyll; Female; Humans; Male; Mice; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Sprague-Dawley; Skin Neoplasms; Tissue Distribution | 2019 |
51 other study(ies) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and chlorophyll a
Article | Year |
---|---|
Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
Topics: Animals; Biological Transport, Active; Chlorophyll; Female; Male; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Mice, Inbred ICR; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Tissue Distribution | 1993 |
The validation of a new vascular damage assay for photodynamic therapy agents.
Topics: Animals; Blood Vessels; Chlorophyll; Fluorescein; Fluoresceins; Mice; Mice, Inbred C3H; Photochemotherapy; Photosensitizing Agents; Reproducibility of Results; Skin; Spectrometry, Fluorescence | 1995 |
Pharmacokinetics of pyropheophorbide-a-hexyl ether in the dog.
Topics: Animals; Chlorophyll; Dogs; Female; Half-Life; Male; Photochemotherapy; Photosensitizing Agents | 1996 |
Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Transformation, Neoplastic; Cheek; Chlorophyll; Cricetinae; Fluorescence; Lasers; Male; Mesocricetus; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents | 1996 |
Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer.
Topics: Animals; Carcinoma, Squamous Cell; Cats; Chlorophyll; Edema; Inflammation; Opportunistic Infections; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 1997 |
Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation.
Topics: Animals; Biotransformation; Blotting, Northern; Cats; Chlorophyll; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Electrophoresis, Polyacrylamide Gel; Female; Humans; In Vitro Techniques; Male; Microsomes, Liver; Molecular Weight; Phenytoin; Photosensitizing Agents; Protein Binding; Rats; Rats, Wistar; Reactive Oxygen Species; Spectrometry, Fluorescence | 1997 |
Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth.
Topics: Adult; Aged; Animals; Anticonvulsants; Area Under Curve; Biotransformation; Cats; Chlorophyll; Chromatography, High Pressure Liquid; Epilepsy; Female; Gingival Overgrowth; Humans; Hydroxylation; Liver; Male; Microsomes; Middle Aged; Phenytoin; Photosensitizing Agents; Rats; Rats, Wistar; Species Specificity; Statistics, Nonparametric; Sulfaphenazole; Tolbutamide | 1999 |
Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study.
Topics: Adenocarcinoma; Animals; Carotenoids; Chlorophyll; Dog Diseases; Dogs; Female; Indocyanine Green; Mammary Neoplasms, Animal; Photosensitizing Agents; Spectrometry, Fluorescence; Spectroscopy, Near-Infrared | 2000 |
2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.
Topics: Animals; Brain Neoplasms; Chlorophyll; Glioma; Humans; Male; Models, Animal; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Nude; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Survival Analysis | 2001 |
Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19.
Topics: Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Chlorophyll; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Liver; Mephenytoin; Microsomes; Mixed Function Oxygenases; Oxcarbazepine; Phenytoin; Recombinant Proteins | 2002 |
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Blood Proteins; Carcinoma, Basal Cell; Chlorophyll; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Esophageal Neoplasms; Humans; Lung Neoplasms; Middle Aged; Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin; Skin Neoplasms | 2003 |
Role of cytokines in photodynamic therapy-induced local and systemic inflammation.
Topics: Animals; Cell Adhesion; Cell Movement; Chemokine CXCL1; Chemokine CXCL2; Chemokines; Chemokines, CXC; Chemotactic Factors; Chlorophyll; Cytokines; E-Selectin; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Inflammation; Intercellular Adhesion Molecule-1; Intercellular Signaling Peptides and Proteins; Interleukin-6; Leukocytes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Monokines; Neutrophils; Photochemotherapy; Photosensitizing Agents; Up-Regulation | 2003 |
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy.
Topics: Antineoplastic Agents; Ceramics; Chlorophyll; Drug Carriers; Hydrolysis; Micelles; Nanotechnology; Particle Size; Photochemotherapy; Photosensitizing Agents; Silanes; Solubility; Spectrometry, Fluorescence; Water | 2003 |
Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives.
Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Cell Survival; Chlorophyll; Darkness; Dihematoporphyrin Ether; Electron Transport Complex IV; Fluorescence; Light; Mice; Microscopy, Confocal; Mitochondria; Photochemotherapy; Photosensitizing Agents; Porphyrins; Rats; Singlet Oxygen; Solubility; Spectrophotometry; Tumor Cells, Cultured | 2003 |
Photodynamic therapy: a means to enhanced drug delivery to tumors.
Topics: Animals; Antibiotics, Antineoplastic; Capillary Permeability; Chlorophyll; Colonic Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Delivery Systems; Drug Synergism; Female; Mice; Mice, Inbred BALB C; Photochemotherapy; Photosensitizing Agents | 2003 |
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Chemokine CCL4; Chlorophyll; Colonic Neoplasms; Endothelium; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; In Situ Nick-End Labeling; Interleukin-6; Macrophage Inflammatory Proteins; Mice; Mice, Inbred BALB C; Neutrophils; Nitroimidazoles; Oxygen; Photochemotherapy; Photosensitizing Agents | 2004 |
Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Capillary Permeability; Chlorophyll; Combined Modality Therapy; Dose-Response Relationship, Drug; Immunohistochemistry; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Photochemotherapy; Platelet Endothelial Cell Adhesion Molecule-1; Treatment Outcome; Xanthones | 2005 |
Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
Topics: Administration, Topical; Aminolevulinic Acid; Chlorophyll; Dihematoporphyrin Ether; Fluorometry; Half-Life; Humans; Infusions, Intravenous; Neoplasms; Photosensitizing Agents | 2006 |
Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy.
Topics: Absorption; Antineoplastic Agents; Chemical Precipitation; Chlorophyll; Fluorescent Dyes; HeLa Cells; Humans; Intracellular Space; Micelles; Nanoparticles; Photochemotherapy; Photons; Photosensitizing Agents; Singlet Oxygen; Spectrometry, Fluorescence | 2007 |
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
Topics: Animals; Blotting, Western; cdc25 Phosphatases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chlorophyll; Colonic Neoplasms; Culture Media, Conditioned; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; HeLa Cells; Humans; Interleukin-6; Macrophages; Mice; Mice, Inbred BALB C; Photochemotherapy; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor | 2007 |
Photophysical, electrochemical characteristics and cross-linking of STAT-3 protein by an efficient bifunctional agent for fluorescence image-guided photodynamic therapy.
Topics: Animals; Carbocyanines; Chlorophyll; Cross-Linking Reagents; Electrochemistry; Fluorescence; Glioma; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Oxidation-Reduction; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen; STAT3 Transcription Factor | 2007 |
Light delivery over extended time periods enhances the effectiveness of photodynamic therapy.
Topics: Animals; Cell Hypoxia; Chlorophyll; Colonic Neoplasms; Female; Light; Oxygen; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Inbred F344; Treatment Outcome | 2008 |
Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo.
Topics: Animals; Biological Transport; Carbohydrates; Cell Line, Tumor; Chlorophyll; Clinical Trials as Topic; Galactose; Hydrophobic and Hydrophilic Interactions; Intracellular Space; Mice; Photochemotherapy; Photosensitizing Agents; Protein Multimerization; Protein Structure, Quaternary; Skin; STAT3 Transcription Factor; Tissue Distribution | 2009 |
Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, Fluorescence) and photodynamic therapy.
Topics: Animals; Chlorophyll; Fluorescence; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms; Photochemotherapy; Rats | 2010 |
Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report.
Topics: Chlorophyll; Cross-Linking Reagents; Fiber Optic Technology; Head and Neck Neoplasms; Hemodynamics; Humans; Male; Photobleaching; Photochemotherapy; STAT3 Transcription Factor | 2010 |
Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy.
Topics: Cell Line, Tumor; Chlorophyll; Chlorophyll A; Chromatography, High Pressure Liquid; Humans; Integrin alphaVbeta3; Magnetic Resonance Spectroscopy; Molecular Structure; Oligopeptides; Photochemotherapy; Photosensitizing Agents | 2011 |
Photodynamic therapy of disseminated non-small cell lung carcinoma in a murine model.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chlorophyll; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Nude; Photochemotherapy; Photosensitizing Agents; Tumor Burden | 2011 |
IL-6 potentiates tumor resistance to photodynamic therapy (PDT).
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Chlorophyll; Colonic Neoplasms; Dihematoporphyrin Ether; Drug Resistance, Neoplasm; Female; Interleukin-6; Lymphocyte Activation; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neutrophils; Photochemotherapy; Photosensitizing Agents; T-Lymphocytes | 2011 |
Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy.
Topics: Acrylic Resins; Animals; Cell Line, Tumor; Chlorophyll; Colonic Neoplasms; Drug Carriers; Mice; Mice, Inbred BALB C; Nanoparticles; Photochemotherapy; Photosensitizing Agents | 2011 |
Imaging a photodynamic therapy photosensitizer in vivo with a time-gated fluorescence tomography system.
Topics: Cell Line, Tumor; Chlorophyll; Equipment Design; Equipment Failure Analysis; Humans; Image Enhancement; Imaging, Three-Dimensional; Metabolic Clearance Rate; Microscopy, Fluorescence; Molecular Imaging; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Reproducibility of Results; Sensitivity and Specificity; Tomography, Optical; Treatment Outcome | 2012 |
Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Chlorophyll; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Humans; Pancreatic Neoplasms; Photochemotherapy; Photosensitizing Agents | 2012 |
Comparative tumor imaging and PDT Efficacy of HPPH conjugated in the mono- and di-forms to various polymethine cyanine dyes: part - 2.
Topics: Animals; Chlorophyll; Disease Models, Animal; Fluorescent Dyes; Humans; Indoles; Mice, Nude; Neoplasms; Optical Imaging; Pathology, Clinical; Photochemotherapy; Staining and Labeling | 2013 |
Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chlorophyll; Copper Radioisotopes; Graphite; Mice; Microscopy, Fluorescence; Multimodal Imaging; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Positron-Emission Tomography | 2014 |
Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease.
Topics: Animals; Antineoplastic Agents; Chlorophyll; Colonic Neoplasms; Dihematoporphyrin Ether; Female; Lymphocyte Activation; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Photochemotherapy; Photosensitizing Agents; Random Allocation; T-Lymphocytes; Transfection | 2015 |
Gap junction enhances phototoxicity of photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH).
Topics: Apoptosis; Biomarkers; Bystander Effect; Caspase 3; Cell Survival; Chlorophyll; Gap Junctions; HeLa Cells; Humans; Photosensitizing Agents; Reactive Oxygen Species | 2015 |
Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chlorophyll; Drug Liberation; Female; Fluoresceins; Humans; Lasers; Light; Liposomes; Luminescent Measurements; Mice; Mice, Nude; Photochemotherapy; Tissue Distribution; Xenograft Model Antitumor Assays | 2015 |
Understanding the interactions between porphyrin-containing photosensitizers and polymer-coated nanoparticles in model biological environments.
Topics: Cell Membrane; Chlorophyll; Drug Delivery Systems; Gold; Humans; Kinetics; Metal Nanoparticles; Models, Biological; Photosensitizing Agents; Polyethylene Glycols; Porphyrins; Surface Properties | 2016 |
Porphyrin-phospholipid liposomes with tunable leakiness.
Topics: Animals; Antibiotics, Antineoplastic; Biological Availability; Chlorophyll; Doxorubicin; Drug Compounding; Drug Stability; Female; HeLa Cells; Humans; Injections, Intravenous; Liposomes; Mice, Nude; Neoplasms; Phospholipids; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Solubility; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
Topics: Animals; Chlorophyll; Disease Models, Animal; Female; Fibrosarcoma; Light; Mice; Mice, Inbred C3H; Necrosis; Neoplasms; Photochemotherapy; Photosensitizing Agents; Radiometry; Singlet Oxygen | 2015 |
Establishment and comparison of three novel methods for the determination of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in human serum.
Topics: Chlorophyll; Chromatography, High Pressure Liquid; Fluorescence; Humans; Photochemotherapy; Photosensitizing Agents; Serum; Tandem Mass Spectrometry | 2016 |
Fluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity.
Topics: Animals; Autoantigens; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chlorophyll; ErbB Receptors; Female; Humans; Lung Neoplasms; Mice; Photochemotherapy; Proteasome Endopeptidase Complex | 2016 |
Structural and Epimeric Isomers of HPPH [3-Devinyl 3-{1-(1-hexyloxy) ethyl}pyropheophorbide-a]: Effects on Uptake and Photodynamic Therapy of Cancer.
Topics: Animals; Cell Line, Tumor; Chlorophyll; Head and Neck Neoplasms; Humans; Isomerism; Lung Neoplasms; Mice; Mice, Inbred BALB C; Molecular Structure; Photochemotherapy; Photosensitizing Agents | 2017 |
Specific Targeting of Melanotic Cells with Peptide Ligated Photosensitizers for Photodynamic Therapy.
Topics: Animals; Cell Proliferation; Chlorophyll; Humans; Ligands; Melanoma; Methylene Blue; Mice; Peptides; Photochemotherapy; Photosensitizing Agents; Receptors, Melanocortin | 2017 |
Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
Topics: Animals; Carbocyanines; Chlorophyll; Colonic Neoplasms; Dose-Response Relationship, Radiation; Fluorescent Dyes; Glycoconjugates; Indoles; Infrared Rays; Mice; Mice, Inbred BALB C; Optical Imaging; Photobleaching; Photochemotherapy; Photosensitizing Agents; Propionates; Radiometry; Singlet Oxygen; Spectrometry, Fluorescence; Xenograft Model Antitumor Assays | 2018 |
Cell-specific Retention and Action of Pheophorbide-based Photosensitizers in Human Lung Cancer Cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Chlorophyll; Female; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Pre-clinical compartmental pharmacokinetic modeling of 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) as a photosensitizer in rat plasma by validated HPLC method.
Topics: Animals; Chlorophyll; Chromatography, High Pressure Liquid; Injections, Intravenous; Kinetics; Photosensitizing Agents; Rats; Rats, Wistar | 2019 |
Evaluation of Light Fluence Distribution Using an IR Navigation System for HPPH-mediated Pleural Photodynamic Therapy (pPDT).
Topics: Chlorophyll; Humans; Infrared Rays; Photochemotherapy; Pleural Neoplasms | 2020 |
Pluronic F-127: An Efficient Delivery Vehicle for 3-(1'-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH or Photochlor).
Topics: Animals; Cell Line, Tumor; Chlorophyll; Humans; Mice; Mice, Inbred BALB C; Neoplasms; Photochemotherapy; Photosensitizing Agents; Poloxamer; Xenograft Model Antitumor Assays | 2020 |
Core-shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions.
Topics: Acrylic Resins; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chlorophyll; Drug Compounding; Fluorescent Dyes; Humans; Hydrophobic and Hydrophilic Interactions; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Nanocapsules; Neoplasms; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Polymers; Polystyrenes; Singlet Oxygen; Tissue Distribution | 2020 |
The Structures of Gd(III) Chelates Conjugated at the Periphery of 3-(1'-Hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) Have a Significant Impact on the Imaging and Therapy of Cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chelating Agents; Chlorophyll; Colonic Neoplasms; Drug Screening Assays, Antitumor; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Optical Imaging; Photosensitizing Agents | 2020 |
Sonodynamic therapy in combination with photodynamic therapy shows enhanced long-term cure of brain tumor.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chlorophyll; Mice; Mice, SCID; Photochemotherapy; Ultrasonic Waves; Xenograft Model Antitumor Assays | 2020 |